Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 65

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 1
Chunk 65
---
 (2,578)(2,578)(2,578)Other transactions impacting noncontrolling interests— — (292)(292)— Balance at September 30, 2025$4 $31,698 $(2,799)$47,028 $(34,126)$41,805 $209 $42,014 $— Nine Months Ended September 30, 2024 (In millions)Common StockAdditional Paid-in CapitalAccumulated Other Comprehensive (Loss)Retained EarningsTreasury StockShareholders' EquityOther Non- controlling InterestsTotal EquityRedeemable Noncontrolling InterestsBalance at December 31, 2023 $4 $30,669 $(1,864)$41,652 $(24,238)$46,223 $21 $46,244 $107 Effect of issuing stock for employee benefit plans517 (117)400 400 Other comprehensive loss(299)(299)(299)— Net income2,010 2,010 232 2,242 — Common dividends declared (per share: $4.20)(1,182)(1,182)(1,182)Repurchase of common stock— (5,057)(5,057)(5,057)Other transactions impacting noncontrolling interests— — (50)(50)(107)Balance at September 30, 2024$4 $31,186 $(2,163)$42,480 $(29,412)$42,095 $203 $42,298 $— 

The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.

7

The Cigna Group

Consolidated Statements of Cash FlowsUnauditedNine Months Ended September 30,(In millions)20252024Cash Flows from Operating ActivitiesNet income$5,014 $2,242 Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization2,053 2,129 Investment (gains) losses, net(76)2,805 Deferred income tax benefit(174)(351)(Gain) loss on sale of businesses(79)106 Net changes in assets and liabilities, net of non-operating effects:Accounts receivable, net(6,911)(10,600)Inventories1,060 577 Reinsurance recoverable